| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.057 | 0.05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |